Compare Heartflow Inc. Common Stock (HTFL) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heartflow Inc. Common Stock vs Johnson & Johnson — how do they compare? Heartflow Inc. Common Stock trades at $48.78 (market cap $4.30B), while Johnson & Johnson trades at $256.81 (market cap $611.90B). The key difference: Johnson & Johnson is far larger — about 142.3× Heartflow Inc. Common Stock's market cap, and Johnson & Johnson pays a 2.11% dividend while Heartflow Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heartflow Inc. Common Stock for 0 Days and Johnson & Johnson for 129 Days on average.
| HTFL | JNJ | |
|---|---|---|
Market Cap | $4.30B | $611.90B |
Volume | 1,616,039 | 9,651,904 |
Sector | Health | Health |
52-Week High | $52.21 | $278.43 |
52-Week Low | $20.49 | $186.00 |
Typical Hold Time | 0 Days | 129 Days |
Enterprise Value | $4.17B | $640.18B |
Dividend Yield | — | 2.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Johnson & Johnson (JNJ) trades at $248.61, down 5.73% over 24 hours, with a bullish technical signal supported by moving averages. The company maintains strong profitability with 67.91% gross margins and 21.48% net income margin, though valuation ratios appear elevated with a P/E of 38.59. Recent earnings show consistent beats except for Q4 2025, with Q3 2026 EPS of $2.59 exceeding expectations. Analyst consensus remains positive with a $282.53 price target, representing 13.6% upside potential from current levels.
JNJ's diversified healthcare portfolio and robust dividend history provide stability, while innovation in pharmaceuticals and medical technology drives growth. Key risks include patent expirations, regulatory challenges, and increasing debt levels. The stock offers defensive characteristics with upside potential from pipeline developments, though current valuation requires careful monitoring of execution against growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heartflow Inc. Common Stock
HeartFlow, Inc. develops AI-powered software that analyzes coronary CT angiography scans to build personalized 3D heart models for coronary artery disease diagnosis, including its FFRct Analysis, Plaque Analysis, and Roadmap Analysis tools.
Read more on HTFL →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
